Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026

IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences (R) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...

QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...
The Malaysian Reserve

Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center

Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
PharmiWeb

Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...
eLife

mRNA Imprinting: transcription apparatus can remotely control cytoplasmic post-transcriptional mechanisms by dozens of proteins

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...
eLife

Gene specificity landscapes for comparative transcriptomic analysis across tissues, cell types, and species

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...